Outset Medical, Inc. (OM) stock
OMNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/3071% below fair value
$3.86−0.31 (-7.43%)
Close on Nov 12, 2026Market cap $72.56MP/E –Yield –
Outset Medical total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Outset Medical's total debt was $98.37M at Sep 30, 2026. For fiscal 2025 it was $96.24M, down 51.2% from the year before. The highest annual figure on record is $197.38M in fiscal 2024.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $96.24M | -51.2% |
| FY2024 | Dec 31, 2024 | $197.38M | +51.7% |
| FY2023 | Dec 31, 2023 | $130.11M | +28.7% |
| FY2022 | Dec 31, 2022 | $101.09M | +218.0% |
| FY2021 | Dec 31, 2021 | $31.79M | +0.3% |
| FY2020 | Dec 31, 2020 | $31.70M | +9.1% |
| FY2019 | Dec 31, 2019 | $29.06M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $98.37M | +3.0% |
| Q2 FY2026 | Jun 30, 2026 | $97.65M | +3.0% |
| Q1 FY2026 | Mar 31, 2026 | $96.94M | +3.0% |
| Q4 FY2025 | Dec 31, 2025 | $96.24M | -51.2% |
| Q3 FY2025 | Sep 30, 2025 | $95.52M | -51.6% |
| Q2 FY2025 | Jun 30, 2025 | $94.81M | -51.9% |
| Q1 FY2025 | Mar 31, 2025 | $94.12M | -52.2% |
| Q4 FY2024 | Dec 31, 2024 | $197.38M | +51.7% |
| Q3 FY2024 | Sep 30, 2024 | $197.18M | +103.7% |
| Q2 FY2024 | Jun 30, 2024 | $196.99M | +103.9% |
| Q1 FY2024 | Mar 31, 2024 | $196.81M | +104.0% |
| Q4 FY2023 | Dec 31, 2023 | $130.11M | +28.7% |
| Q3 FY2023 | Sep 30, 2023 | $96.78M | +224.5% |
| Q2 FY2023 | Jun 30, 2023 | $96.63M | +224.2% |
| Q1 FY2023 | Mar 31, 2023 | $96.48M | +223.9% |
| Q4 FY2022 | Dec 31, 2022 | $101.09M | +218.0% |
| Q3 FY2022 | Sep 30, 2022 | $29.83M | +0.3% |
| Q2 FY2022 | Jun 30, 2022 | $29.81M | +0.3% |
| Q1 FY2022 | Mar 31, 2022 | $29.78M | +0.3% |
| Q4 FY2021 | Dec 31, 2021 | $31.79M | +0.3% |
| Q3 FY2021 | Sep 30, 2021 | $29.74M | +0.3% |
| Q2 FY2021 | Jun 30, 2021 | $29.72M | +2.3% |
| Q1 FY2021 | Mar 31, 2021 | $29.70M | – |
| Q4 FY2020 | Dec 31, 2020 | $31.70M | – |
| Q3 FY2020 | Sep 30, 2020 | $29.65M | – |
| Q4 FY2019 | Dec 31, 2019 | $29.06M | – |
See a number that looks wrong?